Cargando…

Surgery or chemoradiation for stage IB cervical cancer? How cost effectiveness impacts a complex decision

Detalles Bibliográficos
Autor principal:	Cohn, David E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2014
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996268/ https://www.ncbi.nlm.nih.gov/pubmed/24761209 http://dx.doi.org/10.3802/jgo.2014.25.2.79

Ejemplares similares

Cost-utility analysis of treatments for stage IB cervical cancer
por: Katanyoo, Kanyarat, et al.
Publicado: (2014)

Optimal therapy for IB2 and IIA2 cervical cancer: surgery or chemoradiotherapy?
por: Gaffney, David K.
Publicado: (2012)

Adjuvant hysterectomy following primary chemoradiation for stage IB2 and IIA2 cervical cancer: a retrospective comparison of complications for open versus minimally invasive surgery
por: Miller, Heather, et al.
Publicado: (2021)

Correction to: Adjuvant hysterectomy following primary chemoradiation for stage IB2 and IIA2 cervical cancer: a retrospective comparison of complications for open versus minimally invasive surgery
por: Miller, Heather, et al.
Publicado: (2021)

Cost-Effectiveness Analysis of Chemoradiation and Radiotherapy Treatment for Stage IIB and IIIB Cervical Cancer Patients
por: Puspitasari, Irma M, et al.
Publicado: (2021)

Impact of Chemoradiation on Prognosis in Stage IVB Cervical Cancer with Distant Lymphatic Metastasis
por: Kim, Hee Seung, et al.
Publicado: (2013)

Primary radical hysterectomy vs chemoradiation for IB2-IIA cervical cancer: A systematic review and meta-analysis
por: Yan, Ruo-nan, et al.
Publicado: (2020)

Markers of Prognosis for Early Stage Cervical Cancer Patients (Stage IB1, IB2) Undergoing Surgical Treatment
por: Xu, Chen, et al.
Publicado: (2021)

Neoadjuvant chemotherapy followed by fertility-sparing surgery for women with stage IB1 cervical cancer
por: Wang, Dan, et al.
Publicado: (2013)

Chemoradiation with cisplatin followed by either brachytherapy or radical hysterectomy. A non-randomized comparison in FIGO stages IB2-IIA
por: Cetina, Lucely, et al.
Publicado: (2007)

Radical surgery for stage IB2/IIA2 cervical cancer: A large retrospective study
por: Zhou, Fang, et al.
Publicado: (2022)

Impact of hematologic toxicities during concurrent chemoradiation for cervical cancer
por: Shi, Feiya, et al.
Publicado: (2022)

Brachytherapy versus radical hysterectomy after external beam chemoradiation: a non-randomized matched comparison in IB2-IIB cervical cancer patients
por: Cetina, Lucely, et al.
Publicado: (2009)

Practical challenges in patients with stage III NSCLC receiving checkpoint inhibitors after chemoradiation
por: Shukla, Nikhil A, et al.
Publicado: (2020)

Impact of pelvic MRI in routine clinical practice on staging of IB1–IIA2 cervical cancer
por: Zhang, Weifeng, et al.
Publicado: (2019)

Oncologic outcomes of adjuvant chemotherapy alone after radical surgery for stage IB–IIA cervical cancer patients
por: Lee, Kwang-Beom, et al.
Publicado: (2018)

Survival Nomograms after Curative Neoadjuvant Chemotherapy and Radical Surgery for Stage IB2-IIIB Cervical Cancer
por: Marchetti, Claudia, et al.
Publicado: (2018)

The early surgical period in robotic radical hysterectomy is related to the recurrence after surgery in stage IB cervical cancer
por: Paek, Jiheum, et al.
Publicado: (2021)

The prognosis of women with stage IB1-IIB node-positive cervical carcinoma after radical surgery
por: Cheng, Xi, et al.
Publicado: (2004)

Comparison of outcomes between radical hysterectomy followed by tailored adjuvant therapy versus primary chemoradiation therapy in IB2 and IIA2 cervical cancer
por: Park, Jeong-Yeol, et al.
Publicado: (2012)

Effectiveness of adjuvant systemic chemotherapy for intermediate-risk stage IB cervical cancer
por: Matsuo, Koji, et al.
Publicado: (2017)

Monocytosis as a prognostic factor for survival in stage IB and IIA cervical cancer
por: Eo, Wan Kyu, et al.
Publicado: (2018)

Class I hysterectomy in stage Ia2-Ib1 cervical cancer
por: Chen, Long, et al.
Publicado: (2018)

Factors associated with parametrial involvement in patients with stage IB1 cervical cancer: Who is suitable for less radical surgery?
por: Lee, Seung-Ho, et al.
Publicado: (2018)

Randomized study between radical surgery and radiotherapy for the treatment of stage IB–IIA cervical cancer: 20-year update
por: Landoni, Fabio, et al.
Publicado: (2017)

Patient, disease, and survival outcomes for stage IB to stage IV cervical cancer—A population study
por: Wang, Christine, et al.
Publicado: (2023)

Pretreatment risk factors for parametrial involvement in FIGO stage IB1 cervical cancer
por: Yamazaki, Hiroyuki, et al.
Publicado: (2015)

Identifying selection criteria for non‐radical hysterectomy in FIGO stage IB cervical cancer
por: Kasamatsu, Takahiro, et al.
Publicado: (2019)

Ovarian conservation for young women with clinical stage IB–IIB cervical cancer in Japan
por: Matsuo, Koji, et al.
Publicado: (2017)

Successful pregnancy with stage IB2 uterine cervical cancer: A case report
por: Nagasawa, Saya, et al.
Publicado: (2021)

Who should be offered non-radical surgery for early-stage cervical cancer?
por: Bouchard-Fortier, Geneviève, et al.
Publicado: (2015)

A retrospective comparison of outcome in IB2 and IIA cervical cancer patients treated with primary concurrent chemoradiation versus radical hysterectomy with or without tailored adjuvant therapy
por: Jang, Tae-Kyu, et al.
Publicado: (2017)

Comparison of adenocarcinoma and adenosquamous carcinoma prognoses in Chinese patients with FIGO stage IB-IIA cervical cancer following radical surgery
por: Zhang, Xiaojing, et al.
Publicado: (2020)

Neoadjuvant chemotherapy followed by radical surgery reduces radiation therapy in patients with stage IB2 to IIA2 cervical cancer
por: Huang, Yuhui, et al.
Publicado: (2022)

Oxidative stress in cervical cancer and its response to chemoradiation
por: Shah, Saiqa, et al.
Publicado: (2019)

Reducing prolonged chemoradiation treatment times for cervical cancer
por: Vitzthum, Lucas, et al.
Publicado: (2019)

Influence of chemoradiation on the immune microenvironment of cervical cancer patients
por: Herter, J. M., et al.
Publicado: (2022)

Lymphangiogenesis in cervical cancer evaluated by expression of the VEGF-C gene in clinical stage IB-IIIB
por: Franc, Magdalena, et al.
Publicado: (2015)

Robot-assisted versus conventional laparoscopic radical hysterectomy in cervical cancer stage IB1
por: Kim, Sang Il, et al.
Publicado: (2023)

Neoadjuvant Chemotherapy Prior Fertility-Sparing Surgery in Women with FIGO 2018 Stage IB2 Cervical Cancer: A Systematic Review
por: Buda, Alessandro, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7ra025f1b24f4v750b01id7hdl